Quantitative autoradiographic localization of [3H] ABSTRACT Quantitative autoradiography shows that there is a close relationship between [H]imipramine binding sites and the distribution of 5-hydroxytryptamine (5-HT) neurons in the rat brain. High labeling is observed in the midbrain raphe nuclei, the areas of the dopamine cell groups of the substantia nigra and of the ventral tegmental area of Tsai, the ventral amygdaloid nucleus, the midline thalamic area, and parts of the hypothalmus. Thus, antidepressant drugs that have high affinity for [3H]imipramine binding sites can exert an influence at the 5-HT cell body as well as at the 5-HT nerve terminal level. The present results underline the possibility that the 5-HT and dopamine hypotheses for the mechanism of action of antidepressant drugs are not mutually exclusive, because both 5-HT and dopamine neurons can be regulated by large numbers of [3H]imipramine binding sites.
During recent years, high-affinity binding sites for the antidepressant drug [3H]imipramine have been found in membrane fractions from various parts of the brain (1) . The highaffinity [3H]imipramine binding sites have been shown to be located in the 5-hydroxytryptamine (5-HT) nerve cell membrane and seem to participate in regulation of the 5-HT uptake mechanism (2) . Most of the currently used antidepressant drugs have a high affinity for this binding site, indicating its possible importance for the therapeutic activity of antidepressant drugs. These results also underline the importance of 5-HT neurons as targets for antidepressant action (3, 4) (Fig. 1B) , the area medial of the substantia nigra ( Fig. 1) containing the A10 dopamine cell group according to Dahlstrom and Fuxe (8) , and the midline thalamic area [especially within the nucleus periventricularis stellato and rotundocellularis, nucleus reuniens and nucleus periventricularis hypothalami ( Fig. 1 C and D) ] while the superficial layers of the superior colliculus (Figs. 1A and 2 ) and the lateral amygdaloid nucleus (Fig. 1C) that contain a high density of 5-HT nerve terminal systems, such as the substantia nigra, the superior colliculus, and the lateral amygdaloid cortex, which is in line with the view that the [3H]imipramine site is a regulator of 5-HT uptake and release mechanisms (2) . The present findings also indicate that [3H]-imipramine binding sites may also be located in the 5-HT nerve cell membrane of the nonterminal axons. This result is expected in view of the fact that the 5-HT reuptake mechanism is also in this part of the neuron (18 
